Sermorelin Tablet is an oral dosage form product with growth hormone-releasing hormone (GHRH) analog as the core component, specifically designed for convenient growth hormone supplementation and regulation of the body's endocrine balance. Compared with traditional injectable formulations, the tablet has core characteristics of no need for puncture, easy portability and convenient administration, which greatly reduces the use threshold and psychological burden, making it more suitable for long-term regular conditioning.
By accurately stimulating the pituitary gland to secrete endogenous growth hormone after oral administration, it helps improve fatigue, slow metabolism, decreased muscle mass and other problems caused by growth hormone deficiency. Meanwhile, relying on advanced oral sustained-release technology, it prolongs the action time of active ingredients and improves bioavailability.
Our Products Form









Sermorelin COA



Persistent difficulty falling asleep, light sleep, and frequent awakening from dreams not only lead to daytime fatigue and poor concentration, but also trigger negative emotions such as anxiety and depression, forming a vicious cycle of "poor sleep leading to low mood". What is little known is that behind this cycle lies the underlying logic of growth hormone secretion disorder. When growth hormone secretion is insufficient, the balance mechanism between sleep and mood will be disrupted. As a convenient oral dosage form for regulating growth hormone, Sermorelin Tablet is providing a brand-new conditioning pathway for improving sleep quality and regulating emotional states by precisely stimulating the secretion of endogenous growth hormone.
Activating the Balance Switch of Sleep and Mood from the Source
For the conditioning of sleep and mood, its mechanism of action can be divided into three key links.First, regulating the rhythmic secretion of growth hormone. By virtue of advanced oral sustained-release technology, it enables the active ingredients to be slowly released in the body, which exactly matches the peak period of nocturnal growth hormone secretion, helping to prolong the duration of deep sleep and improve problems such as difficulty falling asleep and easy awakening.
Second, indirectly regulating mood-related neurotransmitters.The normal secretion of growth hormone can promote the synthesis and release of dopamine and serotonin in the brain, which are key substances for maintaining emotional stability and relieving anxiety and depression. When growth hormone secretion is insufficient, the levels of these two neurotransmitters will decrease, which in turn triggers emotional fluctuations. By activating pituitary function and increasing endogenous growth hormone levels, it can indirectly improve neurotransmitter balance and alleviate negative emotions.
Third, repairing the vicious cycle of sleep and mood. Long-term poor sleep can inhibit growth hormone secretion, and insufficient growth hormone will further worsen sleep. By precisely regulating growth hormone secretion, it breaks this vicious cycle and achieves bidirectional improvement of sleep quality and emotional state.
Adapting to Long-term Conditioning for Easier Sleep and Mood Management
Compared with traditional injection dosage forms related to growth hormone, the oral dosage form design of it provides great convenience for long-term conditioning of sleep and mood, which is also one of its core competitive advantages in the application of this field.
First, no puncture required, reducing psychological burden. Frequent injections not only bring physical pain, but also cause psychological resistance, making it difficult to adhere to conditioning. In contrast, oral tablets only need to be taken with warm water, featuring simple operation and no trauma, which greatly improves acceptance and compliance.
Second, convenient to carry and take, adapting to diverse life scenarios. The carrying and use of injection dosage forms are subject to many restrictions, while it is small in size and easy to carry around.Third, accurate dosage and higher safety. This dosage form adopts advanced preparation technology to strictly control the content of active ingredients in each tablet, ensuring the accuracy of the dosage taken, and avoiding the dosage deviation that may be caused by improper operation of injection dosage forms.
At the same time, because its function is to stimulate endogenous growth hormone secretion rather than directly supplement exogenous growth hormone, the risk of adverse reactions caused by excessive supplementation is greatly reduced, making it more suitable for long-term safe conditioning.
Scientific Conditioning Suggestions to Maximize the Effect
To better exert the effect of Sermorelin Tablet in improving sleep quality and regulating mood, combined with its mechanism of action and dosage form characteristics, the following scientific conditioning suggestions are put forward.First, grasp the optimal administration time. Since the secretion peak of growth hormone occurs after falling asleep at night, it is recommended to take the tablet 30-60 minutes before bedtime. Taking it at this time can precisely match the release peak of active ingredients in the body with the secretion peak of growth hormone, improving the conditioning effect.Second, cooperate with regular work and rest.
During the administration period, try to maintain a regular work and rest schedule, avoid staying up late, and ensure 7-8 hours of sleep every night. This can provide a good physiological environment for the normal secretion of growth hormone and enhance the conditioning effect.
Meanwhile, reducing the use of electronic products before bedtime and avoiding drinking stimulating beverages such as coffee and strong tea can also help improve sleep quality and enhance the conditioning effect.
Third, follow individualized dosage and course of treatment. Different patients have different growth hormone secretion conditions and varying severity of sleep and mood problems. Therefore, the dosage and course of treatment should be determined under the guidance of doctors or professionals to avoid blind administration and ensure the safety and effectiveness of conditioning.

Synthesis and Activity Verification of it
In the 1980s, the limitations of natural GHRH in clinical applications gradually became prominent. As a peptide substance, natural GHRH has a half-life of only a few minutes in the body, is susceptible to protease degradation, and exhibits extremely poor stability. Frequent administration is required to maintain its therapeutic effect, which severely restricts its clinical utility. In response to these challenges, numerous research teams worldwide launched a race to develop structurally modified and synthetic analogs of GHRH.
In 1984, the research team of Pharmacia & Upjohn (now a subsidiary of Pfizer) in the United States achieved a key breakthrough, successfully synthesizing it - the first clinical-grade GHRH analog. This substance precisely retains the core active fragment (amino acids 1–29) of natural GHRH that is responsible for activating pituitary receptors. Meanwhile, through amino acid sequence optimization, it significantly enhances anti-degradation capability and stability in the body, extending its half-life to more than 30 minutes.
Results from initial clinical trials demonstrated that it can effectively stimulate the pituitary gland to secrete endogenous growth hormone, with definite efficacy in alleviating symptoms such as fatigue and slow metabolism caused by growth hormone deficiency.
More importantly, its "endogenous stimulation" mode avoids the risks of overdose and endocrine disorders that may be induced by exogenous growth hormone supplements, presenting significant safety advantages. This achievement quickly became a research hotspot in the field of endocrine conditioning and laid a solid foundation for subsequent clinical translation.
Research, Development and Application of Oral Tablets
The initially marketed product of it was in injection dosage form. Although its efficacy and safety were well recognized, the invasive injection administration brought multiple inconveniences: frequent injections are prone to cause local pain and induration; moreover, it requires professional operation or rigorous self-injection training, leading to strong psychological resistance in patients and poor long-term compliance, which greatly limited its application in chronic conditioning scenarios.
In the 1990s, the rapid development of oral peptide formulation technology provided possibilities for dosage form innovation. The core challenge faced by research teams was that peptide substances are easily completely degraded by proteases in the gastrointestinal tract after oral administration, and the intestinal mucosal permeability is low, resulting in extremely low bioavailability. To address this, researchers adopted a dual technical scheme of "sustained-release coating + absorption enhancer": a protective film is formed using special sustained-release coating materials to isolate it from erosion by gastrointestinal enzymes; meanwhile, a small intestinal absorption enhancer is added to improve the efficiency of it passing through the intestinal mucosa.
After nearly a decade of technological iteration and clinical trials, in the early 21st century, Sermorelin Tablet officially completed clinical verification and was approved for marketing. This dosage form completely abandons the injection administration mode and only needs to be taken with warm water. It is small in size and easy to carry, which greatly lowers the threshold for use and reduces psychological burden. After its launch, it rapidly expanded the application scenarios of it, extending from the traditional field of clinical treatment to daily health management scenarios such as sleep conditioning and anti-aging health care. It is particularly suitable for populations requiring long-term regular conditioning, driving it to achieve a leap from a "clinical drug" to a "health conditioning product".
FAQ
1.Does taking it orally work?
+
-
It can help people maintain healthy hormone levels, and it can be administered in various ways. Oral therapy, nasal spray, and injections, are all viable options, but it appears that injections are the most effective ways of taking it.
2.What is the best way to take it?
+
-
Inject it subcutaneously at night, five days per week, as part of your growth hormone optimization plan. Administering the injection before sleep supports the body's natural hormone cycles for better results.
3.What are the side effects of the product?
+
-
Some patients occasionally report headaches, flushing, dizziness, or nausea. These symptoms are usually temporary and often resolve with minor adjustments to the treatment plan.
4.Does it reduce belly fat?
+
-
Fat Reduction; The impact of it on growth hormone levels can aid in breaking down stored fat, particularly in stubborn areas such as the abdomen. This contributes to reducing body fat percentage.
Hot Tags: sermorelin tablet, China sermorelin tablet manufacturers, suppliers, salcatonin injection, intranasal desmopressin acetate, best glp 1 peptide, MT2 Injection, glp1 shot, etelcalcetide structure

